AS
Ajay Singh Rathore
About Ajay Singh Rathore
Data last updated:
Ajay Singh Rathore is a Whole-Time Director at Mylan Pharmaceuticals Private Limited (since 2019) and Director at Famy Life Sciences Private Limited (since 2023). The companies operate in Pharma, Trading and Chemicals. The 2 current companies with reported revenue have a combined latest revenue of ₹1,256 Cr; the largest is Mylan Pharmaceuticals Private Limited at ₹1,253 Cr (FY 2025). Earlier, Ajay Singh Rathore was an Additional Director at Tianish Laboratories Private Limited (2023–2024) and Additional Director at Senador Laboratories Private Limited (2023–2024) and 2 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Whole-Time Director | 21 Jun 2019 | 1997 | ₹1,253 Cr (FY 2025) | Active | |
| Director | 10 Feb 2023 | 2008 | ₹2.36 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 27 Mar 2023 | 2023 | ₹2,060 Cr (FY 2024) | Amalgamated | |
| Additional Director | 03 Apr 2023 | 2023 | ₹29.13 Cr (FY 2024) | Active | |
| Director | 04 May 2011 | 2007 | Amalgamated | ||
| Nominee Director | 30 May 2011 | 2007 | ₹1,437 Cr (FY 2026) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Ajay Singh Rathore
| Name | DIN | Company | Designation |
|---|---|---|---|
| Praveen Singh Chauhan | 10593980 | Mylan Pharmaceuticals Private Limited | Whole-Time Director |
| Rekha Lakhotiya | Mylan Pharmaceuticals Private Limited | Company Secretary | |
| Nagaraj Goud Bodige | 10329289 | Famy Life Sciences Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ajay Singh Rathore
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ajay Singh Rathore
Ajay Singh Rathore currently holds 2 directorships: Mylan Pharmaceuticals Private Limited (Whole-Time Director, since 21 Jun 2019, revenue ₹1,253 Cr (FY 2025)); Famy Life Sciences Private Limited (Director, since 10 Feb 2023, revenue ₹2.36 Cr (FY 2025)).
Ajay Singh Rathore was first appointed on 04 May 2011 as Director at Onco Therapies Limited. The most recent appointment on record is 03 Apr 2023 at Senador Laboratories Private Limited.
The 2 current companies of Ajay Singh Rathore that report revenue have a combined latest revenue of ₹1,256 Cr: Mylan Pharmaceuticals Private Limited ₹1,253 Cr (FY 2025); Famy Life Sciences Private Limited ₹2.36 Cr (FY 2025).
Ajay Singh Rathore held 4 earlier board appointments: Tianish Laboratories Private Limited (Additional Director, 27 Mar 2023 to 01 Mar 2024); Senador Laboratories Private Limited (Additional Director, 03 Apr 2023 to 16 Feb 2024); Onco Therapies Limited (Director, 04 May 2011 to 05 Dec 2013); Onesource Specialty Pharma Limited (Nominee Director, 30 May 2011 to 18 Mar 2013).
The current boards of Ajay Singh Rathore's companies include Praveen Singh Chauhan (Mylan Pharmaceuticals Private Limited), Rekha Lakhotiya (Mylan Pharmaceuticals Private Limited), Nagaraj Goud Bodige (Famy Life Sciences Private Limited).